Site Search

Innovative Medicines Initiative (IMI) is launching first eight projects on Ebola, covering vaccine development and manufacture, vaccine uptake, and diagnostics. Projects are part of the wider IMI Ebola+ programme, which is designed to contribute to efforts to tackle a broad range ...

For immediate release IMI2/OUT/2014-04984 3rd Call for proposals includes topic on whooping cough (pertussis) vaccines, which will see IMI collaborate with Bill & Melinda Gates Foundation. Other 3rd Call topics cover: remote assessment of disease; diabetes; psychiatric disorders ...

The end of the year is traditionally a period of reflection and new commitments. For the Innovative Medicines Initiative, it also corresponds to the launch of the first IMI 2 projects and the transition to a new management. Looking back, the accomplishments of IMI during the last ...

Global organizations convene cross-sector thought leaders to discuss public-private partnerships Bethesda, MD, USA | 3 December 2014—Today, the Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) are convening an international group of thought leaders to ...

Comprehensive programme will contribute to tackling wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics and treatments. Today’s €280 million Call for proposals gives experts the opportunity to ...